EyeArt
by Eyenuk, Inc.
Categories
DiagnosticsImagingScreeningChronic Disease
Description
AI technology for autonomous detection of diabetic retinopathy (DR) using retinal images.
Summary
EyeArt is an FDA-cleared AI system designed for the autonomous detection of diabetic retinopathy (DR), including both more than mild and vision-threatening stages. It enables in-clinic, real-time DR screening by analyzing retinal images captured with specific camera models. The system provides immediate results, making it possible for primary care, diabetes centers, and optometric offices to identify referable DR patients during regular exams without the need for human grading.
Use Cases
- Primary care practices screen diabetic patients for referable diabetic retinopathy during regular exams.
- Optometric offices use EyeArt for immediate DR screening results, facilitating timely referral to eye care specialists.
Platforms
Web
Regulatory Status
FDA cleared, CE marked as a class IIb medical device, Health Canada licensedAPI Available
YesAdded to Directory
6/27/2025Target Customer
Clinic